QB
Q BioMed Inc.
QBIO · OTC
$0.00 +0.00% (+$0.00)
Market Cap $14.5K
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.05x
P/FCF 0.01x
P/E N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
30 /100
Weak Gross margin 3.16%
Net margin 721.67%
Op. margin 1,211.74%
Quality
59 /100
Average ROIC 679.02%
ROA 58.37%
Asset turnover 0.08x
Debt
50 /100
Moderate Current ratio 0.01x
Int. coverage -0.48x
Net debt/EBITDA -6.57x
Stability
47 /100
Moderate Beta -154.93x
EPS volatility 29.87%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about QBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Denis D. Corin
Employees
3
Headquarters
New York City